Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 501–600 of 1,027

Efficacy of Sacubitril/Valsartan vs. Enalapril at Lower than Target Doses in Heart Failure with Reduced Ejection Fraction: The PARADIGM-HF Trial
Vardeny, O., Claggett, B. L., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, K. B., Teerlink, J. R., Desai, A. S., Lefkowitz, M. P., Shi, V. C., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.580 · Cited by 235
Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure
Johnson, W., Omland, T., Hall, C., Lucas, C., Myking, O. L., Collins, C. M., Pfeffer, M. A., Rouleau, J. L., & Stevenson, L. W. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01814-4 · Cited by 235
Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome
Samady, H., Elefteriades, J. A., Abbott, B., Mattera, J. A., McPherson, C. A., & Wackers, F. J. T. (1999) · Circulation · doi:10.1161/01.cir.100.12.1298 · Cited by 235
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
Hall, D., Zeitler, H., & Rudolph, W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90449-w · Cited by 235
Nonallergic angioedema: role of bradykinin
Baş, M., Adams, V., Suvorava, T., Niehues, T., Hoffmann, T. K., & Kojda, G. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01427.x · Cited by 234
Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
Murdoch, D. R., McDonagh, T. A., Byrne, J., Blue, L., Farmer, R., Morton, J. J., & Dargie, H. J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70079-7 · Cited by 234
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
Fonarow, G. C., Yancy, C. W., Hernandez, A. F., Peterson, E. D., Spertus, J. A., & Heidenreich, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.027 · Cited by 233
Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction
Lam, C. S. P., Carson, P. E., Anand, I. S., Rector, T. S., Kuskowski, M. A., Michel Komajda, N., McKelvie, R. S., McMurray, J. J. V., Zile, M. R., Massie, B. M., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.970061 · Cited by 233
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
Binkley, P. F., Haas, G. J., Starling, R. C., Nunziata, E., Hatton, P. A., Leier, C. V., & Cody, R. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90098-l · Cited by 233
Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
Tamaki, S., Yamada, T., Okuyama, Y., Morita, T., Sanada, S., Tsukamoto, Y., Masuda, M., Okuda, K., Iwasaki, Y., Yasui, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.025 · Cited by 232
Sleep-Disordered Breathing Occurs Frequently in Stable Outpatients With Congestive Heart Failure
Ferrier, K. A., Campbell, A. J., Yee, B. J., Richards, M., O’Meeghan, T., Weatherall, M., & Neill, A. M. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2116 · Cited by 232
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 232
Mode of Death in Advanced Heart Failure
Carson, P. E., Anand, I. S., O’Connor, C. J., Jaski, B. E., Steinberg, J. S., Lwin, A., Lindenfeld, J., Ghali, J., Barnet, J. H., Feldman, A. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.016 · Cited by 231
Angiotensin II and the Endothelium
Watanabe, T., Barker, T., & Berk, B. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000153321.13792.b9 · Cited by 231
The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229
The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function
Pitt, B., O’Neill, B. J., Feldman, R., Ferrari, R., Schwartz, L., Mudra, H. G., Bass, T. A., Pepine, C. J., Texter, M. J., Haber, H. E., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01461-8 · Cited by 228
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
Struthers, A. D. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80009-1 · Cited by 228
Growth Hormone Improves Cardiac Performance in Experimental Heart Failure
Yang, R., Bunting, S., Gillett, N. A., CLARK, R. G., & Jin, H. (1995) · Circulation · doi:10.1161/01.cir.92.2.262 · Cited by 227
International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children
Rosenthal, D. N., Chrisant, M., Edens, E., Mahony, L., Canter, C. E., Colan, S. D., Dubin, A. M., Lamour, J. M., Ross, R. D., Shaddy, R. E., et al. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.03.018 · Cited by 226
Warfarin Anticoagulation and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction 11This study was supported by Grant MO1-RR00054 from the General Clinical Research Center, funded by the Division of Research Resources, National Institutes of Health, Bethesda, Maryland. The Studies of Left Ventricular Dysfunction (SOLVD) were funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, with a contribution from Merck, Sharpe and Dohme Pharmaceutical Company, West Point, Pennsylvania.
Al-Khadra, A. S., Salem, D. N., Rand, W. M., Udelson, J. E., Smith, J. J., & Konstam, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00006-0 · Cited by 225
Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles
Dore, A., Houde, C., Chan, K., Ducharme, A., Khairy, P., Juneau, M., Marcotte, F., & Mercier, L. (2005) · Circulation · doi:10.1161/circulationaha.105.543470 · Cited by 225
Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?
Stewart, S. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2291 · Cited by 225
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Brunner-La Rocca, H. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2407 · Cited by 224
Sodium Nitroprusside for Advanced Low-Output Heart Failure
Müllens, W., Abrahams, Z., Francis, G. S., Skouri, H. N., Starling, R. C., Young, J. B., Taylor, D. O., & Tang, W. H. W. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.083 · Cited by 224
Comparison of Right and Left Ventricular Responses to Left Ventricular Assist Device Support in Patients With Severe Heart Failure
Barbone, A., Holmes, J. W., Heerdt, P. M., The, A. H. S., Naka, Y., Joshi, N., Daines, M., Marks, A. R., Öz, M. C., & Burkhoff, D. (2001) · Circulation · doi:10.1161/hc3101.093903 · Cited by 224
Heart Failure with Preserved Ejection Fraction: Clinical Characteristics of 4133 Patients Enrolled in the I-PRESERVE Trial
McMurray, J. J. V., Carson, P. E., Michel Komajda, N., McKelvie, R. S., Zile, M. R., Ptaszynska, A., Staiger, C., Donovan, J. M., & Massie, B. M. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.12.010 · Cited by 223
Efficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., TOUTOUZAS, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 223
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure
Wong, M., Staszewsky, L. I., Latini, R., Barlera, S., Glazer, R. D., Aknay, N., Hester, A., Anand, I. S., & Cohn, J. N. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.053 · Cited by 223
Congestive Heart Failure in the United States
Goff, D. C., Pandey, D. K., Chan, F. A., Ortiz, C., & Nichaman, M. Z. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.197 · Cited by 223
Reverse Remodeling From Cardiomyoplasty in Human Heart Failure
Kass, D. A., Baughman, K. L., Pak, P. H., Cho, P. W., Levin, H. R., Gardner, T. J., Halperin, H. R., Tsitlik, J. E., & Acker, M. A. (1995) · Circulation · doi:10.1161/01.cir.91.9.2314 · Cited by 223
Enalapril Does Not Enhance Exercise Capacity in Patients After Fontan Procedure
Kouatli, A., Garcia, J. A., Zellers, T. M., Weinstein, E. M., & Mahony, L. (1997) · Circulation · doi:10.1161/01.cir.96.5.1507 · Cited by 222
Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging
Hundley, W. G., Kizilbash, A. M., Afridi, I., Franco, F., Peshock, R. M., & Grayburn, P. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00409-4 · Cited by 222
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction
Benedict, C. R., Johnstone, D. E., Weiner, D. H., Bourassa, M. G., Bittner, V., Kay, R., Kirlin, P. C., Greenberg, B., Kohn, R. M., Nicklas, J. M., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90385-9 · Cited by 222
Chronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Grobe, J. L., Mecca, A. P., Mao, H., & Katovich, M. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01170.2005 · Cited by 221
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Jessup, M. L., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., MANCINI, D. M., Rahko, P. S., Silver, M. A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.009 · Cited by 221
Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging
Cheong, B., Muthupillai, R., Wilson, J. M., Sung, A., Huber, S., Amin, S. K., Elayda, M. A., Lee, V., & Flamm, S. D. (2009) · Circulation · doi:10.1161/circulationaha.109.852517 · Cited by 220
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure
Kearney, M. T., Fox, K. A. A., Lee, A. J., Prescott, R. J., Shah, A. M., Batin, P. D., Baig, W., Lindsay, S. F., Callahan, T. S., Shell, W. E., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02490-7 · Cited by 220
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
Stevenson, W. G., Stevenson, L. W., Middlekauff, H. R., Fonarow, G. C., Hamilton, M. A., Woo, M. A., Saxon, L. A., Natterson, P. D., Steimle, A. E., Walden, J. A., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00341-x · Cited by 220
Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines 11This work was supported in part by unrestricted grants from Bristol-Myers Squibb Co., Princeton, New Jersey; Burroughs Wellcome Co., Research Triangle Park, North Carolina; Merck & Co., West Point, Pennsylvania; and the Department of Veterans Affairs Research Service.22All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California in San Francisco.
Edep, M. E., Shah, N. B., Tateo, I. M., & Massie, B. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00176-9 · Cited by 220
Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice
Hattori, T., Shimokawa, H., Higashi, M., Hiroki, J., Mukai, Y., Tsutsui, H., Kaibuchi, K., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000127939.16111.58 · Cited by 219
Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension
Thompson, A. M. (2011) · JAMA · doi:10.1001/jama.2011.250 · Cited by 219
Heart Failure in Patients with Diabetes Mellitus
Rosano, G. M. C., Vitale, C., & Seferovic, P. M. (2017) · Cardiac failure review · doi:10.15420/cfr.2016:20:2 · Cited by 219
Risk stratification in chronic heart failure
Cowburn, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0820 · Cited by 219
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
Krumholz, H. M., Anderson, J. L., Bachelder, B. L., Fesmire, F. M., Fihn, S. D., Foody, J. M., Ho, P. M., Kosiborod, M., Masoudi, F. A., & Nallamothu, B. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.012 · Cited by 218
Heart Failure in Frail Elderly Patients: Diagnostic Difficulties, Co-Morbidities, Polypharmacy and Treatment Dilemmas
Lien, C. T. C., Gillespie, N. D., Struthers, A. D., & McMurdo, M. E. T. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00200-8 · Cited by 218
How to develop cost-conscious guidelines
Eccles, M., & Mason, J. M. (2001) · Health Technology Assessment · doi:10.3310/hta5160 · Cited by 218
Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)
Hobbs, R. F., Roalfe, A. K., Davis, R., Davies, M. K., & Hare, R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm102 · Cited by 217
Comorbidity of atrial fibrillation and heart failure
Ling, L., Kistler, P. M., Kalman, J. M., SCHILLING, R. J., & Hunter, R. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.191 · Cited by 217
Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)
Japanese Society of Hypertension (2006) · Hypertension Research · doi:10.1291/hypres.29.s1 · Cited by 217
NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function
Bay, M., Kirk, V., Parner, J., Hassager, C., Nielsen, H., Krogsgaard, K., Trawinski, J., Boesgaard, S., & Aldershvile, J. (2003) · Heart · doi:10.1136/heart.89.2.150 · Cited by 217
Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease
(1995) · Circulation · doi:10.1161/01.cir.92.2.212 · Cited by 217
The Renin-Angiotensin-Aldosterone System and Heart Failure
SAYER, G. T., & Bhat, G. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.09.002 · Cited by 216
Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)
Guidelines, S. (2006) · Hypertension Research · Cited by 216
Heart failure: a growing public health problem
Eriksson, H. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01153.x · Cited by 216
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00856-8 · Cited by 215
Quality of Care by Race and Gender for Congestive Heart Failure and Pneumonia
Ayanian, J. Z., Weissman, J. S., Chasan-Taber, S., & Epstein, A. M. (1999) · Medical Care · doi:10.1097/00005650-199912000-00009 · Cited by 215
Influence of diabetes mellitus on heart failure risk and outcome
Bauters, C., Lamblin, N., Fadden, E. P. M., BELLE, E. V., Millaire, A., & de Groote, P. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-1 · Cited by 214
Understanding cardiac output
Vincent, J. (2008) · Critical Care · doi:10.1186/cc6975 · Cited by 214
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction
Rocca, H. B., Linssen, G. C. M., Smeele, F. J., van Drimmelen, A. A., Schaafsma, H. J., Westendorp, P. H., Rademaker, P. C., van de Kamp, H. J., Hoes, A. W., & Brugts, J. J. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.10.010 · Cited by 213
Population Impact of Heart Failure and the Most Common Forms of Cancer
Stewart, S., Ekman, I., Ekman, T., Odén, A., & Rosengren, A. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957571 · Cited by 212
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials
Rivero‐Ayerza, M., Theuns, D. A. M. J., García‐García, H. M., Boersma, E. H., Simoons, M. L., & Jordaens, L. J. L. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl203 · Cited by 212
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
Raymond, I. E., Pedersen, F., Steensgaard-Hansen, F., Green, A., Busch-Sørensen, M., Tuxen, C., Appel, J., Jacobsen, J., Atar, D., & Hildebrandt, P. (2003) · Heart · doi:10.1136/heart.89.12.1422 · Cited by 212
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
Jones, A. L., Barlow, M., Barrett-Lee, P. J., Canney, P. A., Gilmour, I., Robb, S. D., Plummer, C., Wardley, A. M., & Verrill, M. W. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604909 · Cited by 211
State of the Art: Clinical Applications of Cardiac T1 Mapping
Schelbert, E. B., & Messroghli, D. (2016) · Radiology · doi:10.1148/radiol.2016141802 · Cited by 211
Comparison of Surgical and Medical Group Survival in Patients With Left Main Equivalent Coronary Artery Disease
Caracciolo, E. A., Davis, K. B., Sopko, G. S., Kaiser, G. C., Corley, S. D., Schaff, H. V., Taylor, H. A., & CHAITMAN, B. R. (1995) · Circulation · doi:10.1161/01.cir.91.9.2335 · Cited by 211
Pathophysiological effects of aldosterone in cardiovascular tissues
Rocha, R., & Stier, C. T. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00432-5 · Cited by 210
Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease
de Freitas, H. F. G., Chizzola, P. R., Paes, Â. T., Lima, A. C. P., & Mansur, A. J. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.025 · Cited by 209
Peripartum cardiomyopathy
Lampert, M. B., & Lang, R. M. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90089-6 · Cited by 209
The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure
McKelvie, R. S., Moe, G. W., Ezekowitz, J. A., Heckman, G. A., Costigan, J., Ducharme, A., Estrella-Holder, E., Giannetti, N., Grzeslo, A., Harkness, K., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.007 · Cited by 208
Angiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernández, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 208
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Docherty, K. F., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M., Martínez, F. A., Ponikowski, P. P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa183 · Cited by 208
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 207
Angiotensin II Type 1A Receptor Knockout Mice Display Less Left Ventricular Remodeling and Improved Survival After Myocardial Infarction
Harada, K., Sugaya, T., Murakami, K., Yazaki, Y., & Komuro, I. (1999) · Circulation · doi:10.1161/01.cir.100.20.2093 · Cited by 207
Blood Urea Nitrogen and Serum Creatinine
Schrier, R. W. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.770834 · Cited by 206
Effects of Chronic ACE Inhibition on Sympathetic Nerve Traffic and Baroreflex Control of Circulation in Heart Failure
Grassi, G. M., Cattaneo, B. M., Seravalle, G., Lanfranchi, A. K., Pozzi, M., Morganti, A., Carugo, S., & Mancia, G. (1997) · Circulation · doi:10.1161/01.cir.96.4.1173 · Cited by 206
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction
Ishani, A., Weinhandl, E. D., Zhao, Z., Gilbertson, D. T., Collins, A. J., Yusuf, S., & Herzog, C. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.038 · Cited by 206
Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy
Stevenson, L. W., Miller, L. W., Desvigne-Nickens, P. M., Ascheim, D. D., Parides, M. K., Renlund, D. G., Oren, R. M., Krueger, S. K., Costanzo, M. R., Wann, L. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000139862.48167.23 · Cited by 206
Carvedilol
Frishman, W. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812103392407 · Cited by 206
Antithrombotic Therapy for Coronary Artery Disease
Harrington, R. A., Becker, R. C., Ezekowitz, M. D., Meade, T. W., O’Connor, C. M., Vorchheimer, D. A., & Guyatt, G. H. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.513s · Cited by 204
Normal Reference Intervals for Cardiac Dimensions and Function for Use in Echocardiographic Practice: A Guideline from the British Society of Echocardiography
Harkness, A., Ring, L. S., Augustine, D. X., Oxborough, D., Robinson, S., & Sharma, V. (2020) · Echo Research and Practice · doi:10.1530/erp-19-0050 · Cited by 203
Mode of death in chronic heart failure: A request and proposition for more accurate classification
Narang, R., Cleland, J. G. F., Erhardt, L., Ball, S., Coats, A. J. S., Cowley, A., Dargie, H. J., Hall, A. S., Hampton, J. R., & Poole-Wilson, A. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015074 · Cited by 203
Pulsatile Stretch Remodels Cell-to-Cell Communication in Cultured Myocytes
Zhuang, J., Yamada, K. A., Saffitz, J. E., & Kléber, A. G. (2000) · Circulation Research · doi:10.1161/01.res.87.4.316 · Cited by 203
Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene
Keavney, B. D., McKenzie, C. A., Connell, J. M. C., Julier, C., Ratcliffe, P. J., Sobel, E. M., Lathrop, M. G., & Farrall, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.11.1745 · Cited by 202
Kidney-Heart Interactions
Berl, T., & Henrich, W. L. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00730805 · Cited by 201
Effect of a Heart Failure Program on Hospitalization Frequency and Exercise Tolerance
Hanumanthu, S., Butler, J., Chomsky, D. B., Davis, S. F., & Wilson, J. R. (1997) · Circulation · doi:10.1161/01.cir.96.9.2842 · Cited by 201
SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
Lam, C. S. P., Chandramouli, C., Ahooja, V., & Verma, S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013389 · Cited by 200
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
MYERS, J. N., Gullestad, L. L., Vagelos, R. H., Do, D., Bellin, D., Ross, H. J., & Fowler, M. B. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90312-0 · Cited by 199
ABC of heart failure: Clinical features and complications
Watson, R. D. (2000) · BMJ · doi:10.1136/bmj.320.7229.236 · Cited by 198
Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure.
Willenheimer, R. B., Cline, C. M. J., Erhardt, L., & Israelsson, B. (1997) · Heart · doi:10.1136/hrt.78.3.230 · Cited by 198
Neuroendocrine activation in heart failure is modified by endurance exercise training
Braith, R. W., Welsch, M. A., Feigenbaum, M. S., Kluess, H. A., & Pepine, C. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00339-3 · Cited by 198
Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?
Uretsky, B. F., & Sheahan, R. G. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00361-6 · Cited by 197
The Clinical Course of Idiopathic Dilated Cardiomyopathy
SUGRUE, D. D., Rodeheffer, R. J., Codd, M., Ballard, D., Fuster, V., & Gersh, B. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-117 · Cited by 197
Fortnightly Review: Diagnosis and management of heart failure
Dargie, H. J., & McMurray, J. J. V. (1994) · BMJ · doi:10.1136/bmj.308.6924.321 · Cited by 197
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
The ARB Trialists Collaboration (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328344a7de · Cited by 196
Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure
Anand, I. S., Carson, P. E., Galle, E. G., Song, R., BOEHMER, J. P., Ghali, J. K., Jaski, B. E., Lindenfeld, J. M., O’Connor, C. M., Steinberg, J. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.793273 · Cited by 196
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Jhund, P. S., & McMurray, J. J. V. (2016) · Heart · doi:10.1136/heartjnl-2014-306775 · Cited by 196
G Protein-Coupled Receptors: A Century of Research and Discovery
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 196
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
Aronow, W. S., & Kronzon, I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90520-m · Cited by 196
Statewide Quality Improvement Initiatives and Mortality After Cardiac Surgery
Ghali, W. A. (1997) · JAMA · doi:10.1001/jama.1997.03540290031028 · Cited by 196
Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
Baruch, L., Anand, I. S., Cohen, I. S., Ziesche, S., Judd, D., & Cohn, J. N. (1999) · Circulation · doi:10.1161/01.cir.99.20.2658 · Cited by 196

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks